Kosuke Ichikawa Selected Research

Kosuke Ichikawa Research Topics

13	Neoplasms (Cancer) 07/2022 - 01/2011
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2011
9	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2015
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2022 - 01/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2021 - 01/2020
2	Pneumonia (Pneumonitis) 04/2021 - 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Diarrhea 01/2021
1	Adenocarcinoma of Lung 11/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2020
1	Brain Neoplasms (Brain Tumor) 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Disease Progression 01/2018
1	Adenocarcinoma 01/2015
1	Lymphopenia (Lymphocytopenia) 09/2012

5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2011
4	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2011
2	PlatinumIBA 09/2022 - 01/2018
2	AfatinibIBA 01/2022 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2018
2	LigandsIBA 01/2020 - 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022
1	amrubicinIBA 09/2022
1	Albumin-Bound Paclitaxel FDA Link 07/2022
1	130-nm albumin-bound paclitaxelIBA 07/2022
1	AntibodiesIBA 06/2022
1	Immune Checkpoint ProteinsIBA 06/2022
1	VimentinIBA 01/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022
1	ProcalcitoninIBA 01/2022
1	Cilastatin FDA Link 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	Loperamide (Imodium)FDA LinkGeneric 01/2021
1	NucleotidesIBA 11/2020
1	Ribosomal DNA (rDNA)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	AntigensIBA 09/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2012
1	EpitopesIBA 09/2012
1	Interleukin-23 (Interleukin 23)IBA 09/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012
1	Gefitinib (Iressa)FDA Link 01/2011

11	Therapeutics 09/2022 - 01/2011
6	Drug Therapy (Chemotherapy) 09/2022 - 11/2011
4	Immunotherapy 07/2015 - 11/2011
2	Radiotherapy 11/2019 - 11/2011
1	Hematopoietic Stem Cell Transplantation 04/2021
1	Drug Tapering 01/2021
1	Retreatment 01/2011